BR112021006498A2 - métodos de inativação de vírus para fabricação contínua de anticorpos - Google Patents
métodos de inativação de vírus para fabricação contínua de anticorposInfo
- Publication number
- BR112021006498A2 BR112021006498A2 BR112021006498A BR112021006498A BR112021006498A2 BR 112021006498 A2 BR112021006498 A2 BR 112021006498A2 BR 112021006498 A BR112021006498 A BR 112021006498A BR 112021006498 A BR112021006498 A BR 112021006498A BR 112021006498 A2 BR112021006498 A2 BR 112021006498A2
- Authority
- BR
- Brazil
- Prior art keywords
- virus inactivation
- methods
- inactivation methods
- manufacturing
- continuous
- Prior art date
Links
- 230000002779 inactivation Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000003599 detergent Substances 0.000 abstract 2
- 230000003612 virological effect Effects 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 238000010924 continuous production Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/06—Inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13061—Methods of inactivation or attenuation
- C12N2740/13063—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
métodos de inativação de vírus para fabricação contínua de anticorpos. a presente invenção refere-se a métodos para uso em inativação de vírus. os métodos de inativação viral são para uso no pro-cesso contínuo de fabricação de um produto biológico, tal como um anticorpo, e incluem separar um eluato usando uma coluna, submeter o referido eluato a um tratamento ortogonal de ph baixo e detergente simultaneamente, no qual o tempo para a inativação viral é reduzido. além disso, o detergente pode ser adicionado ao sistema tampão no processo de purificação para obter o mesmo efeito. o produto biológico em cada caso de tratamento é retido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862767652P | 2018-11-15 | 2018-11-15 | |
PCT/US2019/061436 WO2020102505A1 (en) | 2018-11-15 | 2019-11-14 | Viral inactivation methods for continuous manufacturing of antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021006498A2 true BR112021006498A2 (pt) | 2021-07-06 |
Family
ID=69024584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021006498A BR112021006498A2 (pt) | 2018-11-15 | 2019-11-14 | métodos de inativação de vírus para fabricação contínua de anticorpos |
Country Status (16)
Country | Link |
---|---|
US (1) | US20220002679A1 (pt) |
EP (1) | EP3880806A1 (pt) |
JP (1) | JP2022507369A (pt) |
KR (1) | KR20210091709A (pt) |
CN (1) | CN113015795A (pt) |
AR (1) | AR117081A1 (pt) |
AU (1) | AU2019380308A1 (pt) |
BR (1) | BR112021006498A2 (pt) |
CA (1) | CA3119629A1 (pt) |
IL (1) | IL282944A (pt) |
MX (1) | MX2021005685A (pt) |
PE (1) | PE20211140A1 (pt) |
SG (1) | SG11202103790WA (pt) |
TW (1) | TW202039836A (pt) |
WO (1) | WO2020102505A1 (pt) |
ZA (1) | ZA202104083B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115873810B (zh) * | 2022-12-26 | 2024-02-09 | 苏州良辰生物医药科技有限公司 | 一种鼠白血病病毒的纯化方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3133338B2 (ja) * | 1992-12-16 | 2001-02-05 | イムノ・アクチエンゲゼルシャフト | ウイルス的に安全な生物学的組成物の調製方法 |
IL136552A (en) * | 2000-06-05 | 2005-05-17 | Omrix Biopharmaceuticals Ltd | Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration |
CA2808116C (en) * | 2010-07-30 | 2016-06-07 | Pfizer Inc. | Tandem purification of proteins |
CN104411820B (zh) * | 2012-06-29 | 2017-05-03 | Emd密理博公司 | 在蛋白纯化过程中灭活病毒的方法 |
US10188732B2 (en) | 2012-08-06 | 2019-01-29 | Biogen Ma Inc. | Methods and compositions for inactivating enveloped viruses |
CA2930687C (en) | 2013-11-15 | 2024-04-23 | Genentech, Inc. | Methods for viral inactivation using eco-friendly detergents |
EP4234569A3 (en) * | 2014-04-15 | 2023-10-18 | Boehringer Ingelheim International GmbH | Method and use for continuously inactivating a virus during manufacture of a biological product |
WO2016207328A1 (en) * | 2015-06-24 | 2016-12-29 | Glycotope Gmbh | PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES |
-
2019
- 2019-11-14 SG SG11202103790WA patent/SG11202103790WA/en unknown
- 2019-11-14 WO PCT/US2019/061436 patent/WO2020102505A1/en unknown
- 2019-11-14 CA CA3119629A patent/CA3119629A1/en active Pending
- 2019-11-14 BR BR112021006498A patent/BR112021006498A2/pt not_active IP Right Cessation
- 2019-11-14 AU AU2019380308A patent/AU2019380308A1/en active Pending
- 2019-11-14 JP JP2021526241A patent/JP2022507369A/ja active Pending
- 2019-11-14 CN CN201980074580.XA patent/CN113015795A/zh active Pending
- 2019-11-14 KR KR1020217014291A patent/KR20210091709A/ko unknown
- 2019-11-14 US US17/292,652 patent/US20220002679A1/en active Pending
- 2019-11-14 PE PE2021000699A patent/PE20211140A1/es unknown
- 2019-11-14 AR ARP190103352A patent/AR117081A1/es unknown
- 2019-11-14 TW TW108141336A patent/TW202039836A/zh unknown
- 2019-11-14 EP EP19828357.4A patent/EP3880806A1/en active Pending
- 2019-11-14 MX MX2021005685A patent/MX2021005685A/es unknown
-
2021
- 2021-05-05 IL IL282944A patent/IL282944A/en unknown
- 2021-06-14 ZA ZA2021/04083A patent/ZA202104083B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA3119629A1 (en) | 2020-05-22 |
ZA202104083B (en) | 2023-01-25 |
SG11202103790WA (en) | 2021-05-28 |
JP2022507369A (ja) | 2022-01-18 |
IL282944A (en) | 2021-06-30 |
CN113015795A (zh) | 2021-06-22 |
MX2021005685A (es) | 2021-07-07 |
AU2019380308A1 (en) | 2021-05-13 |
US20220002679A1 (en) | 2022-01-06 |
KR20210091709A (ko) | 2021-07-22 |
AR117081A1 (es) | 2021-07-07 |
TW202039836A (zh) | 2020-11-01 |
WO2020102505A1 (en) | 2020-05-22 |
EP3880806A1 (en) | 2021-09-22 |
PE20211140A1 (es) | 2021-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890763A1 (ru) | Библиотеки вариантных олигонуклеиновых кислот и их синтез | |
BR112017012944A2 (pt) | ?anticorpo, composição farmacêutica, molécula de polinucleotídeo isolada, vetor, célula, e, método para prevenção, tratamento ou melhoria de pelo menos um sintoma de infecção de influenza? | |
BR112018011711A2 (pt) | peptídeos de direcionamento para direcionar virus adeno-associados (aav) | |
BR112015022790A8 (pt) | molécula biespecífica, composição farmacêutica, método de tratamento de uma infecção por vírus latente em um indivíduo em necessidade de tal tratamento, método de tratamento de uma infecção por vírus persistente em um indivíduo em necessidade de tal tratamento, método de tratamento de uma infecção por vírus inativo em um indivíduo em necessidade de tal tratamento, método para exterminar uma célula que contém um genoma viral, e, método para exterminar uma célula que expressa uma proteína viral | |
BR112018075516A2 (pt) | purificação de anticorpos multiespecíficos | |
EA201890039A1 (ru) | Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения | |
BR112019011582A2 (pt) | anticorpos e métodos de utilização dos mesmos | |
BR112015017307A2 (pt) | composições de espécies com baixa acidez e métodos para produção e uso das mesmas | |
BR112017015833A2 (pt) | compostos anti-senescência e usos dos mesmos | |
MX2017011121A (es) | Uso de lavados alcalinos durante la cromatografia para remover impurezas. | |
BR112016016916A8 (pt) | uso de um anticorpo que se liga à calicreína plasmática ativa para tratamento de angiodema hereditário (hae) | |
EA201590826A1 (ru) | Способы очистки арилсульфатазы а | |
EA201790160A1 (ru) | Способы лечения инфекций, вызываемых вирусами гепатита b и гепатита d | |
MX2016017115A (es) | Metodos y reactivos para la purificacion de proteinas. | |
EA201692255A1 (ru) | Улучшенные формы селективного ингибитора pi3k-дельта для применения в фармацевтических препаратах | |
EA201990593A1 (ru) | Непрерывный способ для снижения гетерогенности терапевтического белка | |
CL2019003248A1 (es) | Disminución de homocisteína mediada por enzimas humanas para el tratamiento de pacientes con hiperhomocisteinemia y homocistinuria. | |
BR112021018409A2 (pt) | Anticorpos e métodos para tratamento de infecção por influenza a | |
BR112016014824A2 (pt) | Método para purificar anticorpo que tem ponto isoelétrico baixo | |
BR112021006498A2 (pt) | métodos de inativação de vírus para fabricação contínua de anticorpos | |
EA201691834A1 (ru) | Новый способ очистки гонадотропина | |
UY37065A (es) | Método de purificación | |
BR112017016492A2 (pt) | processo para a purificação de ga-68 a partir de eluato que deriva de geradores de 68ge/ 68ga e colunas cromatográficas para uso no dito processo | |
RU2014124569A (ru) | Способ выделения нуклеиновых кислот | |
CO7230337A2 (es) | Métodos y composiciones para tratar enfermedades virales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2748 DE 05-09-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |